Dosage Form : Premedicate for the first 4 infusions and subsequently as needed.
• Merkel Cell Carcinoma: 800 mg every 2 weeks
• Urothelial Carcinoma; 800 mg every 2 weeks.
• Renal Cell Carcinoma: 800 mg every 2 weeks .
5 mg orally twice daily in combination with axitinib 5 mg orally twice daily .
Administer BAVENCIO as an intravenous infusion over 60 minutes
Side Effect:Most common adverse reactions (> 20%) were: fatigue, musculoskeletal pain, diarrhea, nausea, infusion-related reaction, rash, a This indication is approved under accelerated approval based on tumor decreased appetite, and peripheral edema.